3
Announcements
Trials
Browse
Landscape
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Other hematologic neoplasm
1
Lymphoid
1
Head & Neck
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Urologic Neoplasms
1
Stomach Neoplasms
1
Lymphoma
1
Lung Neoplasms
1
Liver Neoplasms
1
Leukemia
1
Head and Neck Neoplasms
1
Breast Neoplasms
1
Interventions
pembrolizumab
4
Nivolumab
3
Interleukin-2
3
Cyclophosphamide
3
fludarabine phosphate
2
fludarabine
2
atezolizumab
2
aldesleukin
2
Polymerase Chain Reaction
2
Drug Therapy
2
Blood Specimen Collection
2
Biopsy
2
zimberelimab
1
vactosertib
1
ulixertinib
1
trastuzumab biosimilar HLX02
1
trametinib
1
tanespimycin
1
sapanisertib
1
relatlimab
1
pertuzumab
1
palbociclib
1
osimertinib
1
omipalisib
1
larotrectinib
1
ipatasertib
1
fialuridine
1
erdafitinib
1
epacadostat
1
entinostat
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Stomach Neoplasms
×
Tissue Banks
×
Lymphoid
×
Clear all
NCT06827639
2025-02-14
FUTURE
Assistance Publique Hopitaux De Marseille
Not yet recruiting
640 enrolled